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BACKGROUND
The systematic evaluation of the results of time-series studies of air pollution is challenged 
by differences in model specification and publication bias.
METHODS
We evaluated the associations of inhalable particulate matter (PM) with an aerodynamic 
diameter of 10 μm or less (PM10) and fine PM with an aerodynamic diameter of 2.5 μm 
or less (PM2.5) with daily all-cause, cardiovascular, and respiratory mortality across multi-
ple countries or regions. Daily data on mortality and air pollution were collected from 652 
cities in 24 countries or regions. We used overdispersed generalized additive models with 
random-effects meta-analysis to investigate the associations. Two-pollutant models were 
fitted to test the robustness of the associations. Concentration–response curves from each 
city were pooled to allow global estimates to be derived.
RESULTS
On average, an increase of 10 μg per cubic meter in the 2-day moving average of PM10 
concentration, which represents the average over the current and previous day, was associ-
ated with increases of 0.44% (95% confidence interval [CI], 0.39 to 0.50) in daily all-cause 
mortality, 0.36% (95% CI, 0.30 to 0.43) in daily cardiovascular mortality, and 0.47% (95% 
CI, 0.35 to 0.58) in daily respiratory mortality. The corresponding increases in daily mortal-
ity for the same change in PM2.5 concentration were 0.68% (95% CI, 0.59 to 0.77), 0.55% 
(95% CI, 0.45 to 0.66), and 0.74% (95% CI, 0.53 to 0.95). These associations remained 
significant after adjustment for gaseous pollutants. Associations were stronger in locations 
with lower annual mean PM concentrations and higher annual mean temperatures. The 
pooled concentration–response curves showed a consistent increase in daily mortality with 
increasing PM concentration, with steeper slopes at lower PM concentrations.
CONCLUSIONS
Our data show independent associations between short-term exposure to PM10 and PM2.5 
and daily all-cause, cardiovascular, and respiratory mortality in more than 600 cities across 
the globe. These data reinforce the evidence of a link between mortality and PM concentra-
tion established in regional and local studies. (Funded by the National Natural Science 
Foundation of China and others.)
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The adverse health effects of short-term exposure to ambient air pollution are well documented.1-3 Particulate matter (PM), 
especially, arouses public health concerns be-
cause of its toxicity and the widespread human 
exposure to this pollutant. PM, which includes 
inhalable particles with an aerodynamic diameter 
of 10 μm or less (PM10) and fine particles with 
an aerodynamic diameter of 2.5 μm or less 
(PM2.5), is emitted from combustion sources or 
formed through atmospheric chemical transfor-
mation. Given the extensive evidence regarding 
their effects of health, the daily and annual 
mean concentrations of PM10 and PM2.5 are regu-
lated according to the World Health Organiza-
tion (WHO) Air Quality Guidelines4 and standards 
in major countries.
Numerous time-series studies have examined 
the associations between short-term PM expo-
sures and daily mortality.5-9 However, most evi-
dence has been obtained from studies in single 
cities, regions, or countries, and there are chal-
lenges in comparing these results and in synthe-
sizing effect estimates because of different mod-
eling approaches and potential publication bias. 
These limitations can be addressed by perform-
ing international, multicenter studies that adopt 
the same analytic protocol and model specifica-
tions to estimate globally representative asso-
ciations of PM10 and PM2.5 exposures with daily 
mortality. We established the Multi-City Multi-
Country (MCC) Collaborative Research Network 
to perform a global assessment of the effects of 
weather or climate on mortality.10,11 This network 
allowed us to examine and compare the associa-
tions of PM concentrations with daily all-cause, 
cardiovascular, and respiratory mortality at the 
global, regional, and country level with the use of 
a standardized analytic framework.
Me thods
Data Collection
We obtained health and environmental data from 
the MCC database, which has been described 
previously.10,12 The current analysis was limited 
to locations that had available data on air pollu-
tion (652 urban areas in 24 countries or regions, 
with the data covering the period from 1986 
through 2015) (Table S1 in the Supplementary 
Appendix, available with the full text of this arti-
cle at NEJM.org). Data on mortality were obtained 
from local authorities within each country. Causes 
of death were classified according to codes in the 
International Classification of Diseases, 9th Revision 
(ICD-9) or 10th Revision (ICD-10), whichever was 
available. In each location, mortality was repre-
sented by daily counts of either death from non-
external causes (ICD-9 codes 0 to 799 and ICD-10 
codes A0 to R99) or, when such data were un-
available, daily counts of death from any cause. 
We also collected mortality data for two main 
causes of death: cardiovascular disease (ICD-10 
codes I00 to I99) and respiratory disease (ICD-10 
codes J00 to J99).13
We obtained daily data on PM10 in 598 cities 
and on PM2.5 in 499 cities. Data on both pollutants 
were available in 445 cities in 16 countries or re-
gions. The geographic distributions of the cities 
that had data on PM10 and PM2.5, as well as the 
annual mean PM concentrations over the period 
studied for each city, are provided in Figure 1 and 
Figure 2, respectively (also see the interactive map, 
available at NEJM.org). Daily data on gaseous pol-
lutants (ozone, nitrogen dioxide, sulfur dioxide, 
and carbon monoxide) were obtained where avail-
able. We also collected data on the daily mean 
temperature and daily mean relative humidity. To 
avoid potential consequences of including outly-
ing values of exposure data, we used trimmed 
data, in which the highest 5% and lowest 5% of 
PM10 and PM2.5 measurements were excluded.
14
Statistical Analysis
The associations of PM10 and PM2.5 concentrations 
with daily all-cause, cardiovascular, and respira-
tory mortality were assessed in separate analyses 
with the use of a standard time-series approach. 
We followed a two-stage analytic protocol, which 
had been developed and widely applied in previ-
ous multicity time-series studies.15,16
In the first stage, we estimated city-specific 
associations of PM concentration with mortality 
using quasi-Poisson generalized additive models. 
In accordance with the approaches used in previ-
ous studies,16,17 the following covariates were in-
cluded in the main model: a natural cubic smooth 
function with 7 degrees of freedom (df) per year 
to control for underlying time trends in mortal-
ity, an indicator day-of-week variable to account 
for short-term weekly variations, and natural 
spline functions with 6 df for temperature and 3 df 
A Quick Take is 
available at 
NEJM.org 
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for relative humidity to control for potentially 
nonlinear confounding effects of weather condi-
tions in areas where such data were available. To 
determine an appropriate lag time (i.e., the num-
ber of days between exposure and the estimated 
effect) for PM and temperature to be used in the 
main analyses, we compared a variety of lag days 
using generalized cross-validation scores.
In the second stage, we used random-effects 
models to pool the estimates of the city-specific 
associations of PM concentrations with mortality.18 
We then reported the pooled estimate and re-
lated 95% confidence intervals as the percentage 
change in daily mortality per 10-μg-per-cubic-
meter increase in PM concentrations. Between-
city heterogeneity was quantified with the use of 
the I2 statistic.
In addition to the main model described 
above, we fitted two-pollutant models, each of 
which included adjustment for one of four gas-
eous pollutants. The association of PM concen-
tration with mortality was considered robust if 
the effect estimates in the single-pollutant and 
two-pollutant models were not significantly dif-
ferent, as determined with a paired z-test.
Using the aforementioned two-stage approach, 
we also performed regional analyses, with the 
regions grouped according to WHO region and 
according to the gross domestic product (GDP) 
per capita (Table S2 in the Supplementary Ap-
pendix), and likelihood-ratio tests were used to 
determine whether the differences between re-
gions in associations of PM with mortality were 
significant. To further explore potential effect 
modifications, we fit meta-regression models 
with annual mean concentrations of PM and 
copollutants, annual mean temperature, latitude 
of locations, WHO region and region classified 
according to the GDP per capita, rates of miss-
ing data on daily mortality and PM10 and PM2.5 
concentrations, and GDP per capita.
To estimate the overall shape of the associa-
tions between PM10 and PM2.5 concentrations and 
mortality at the global or country level, we plot-
An interactive map 
is available at 
NEJM.org   
Figure 1. Distribution of the Cities with Data on PM10.
Shown is the geographic distribution of the 598 cities in the 24 countries and regions that had available data on particulate matter with 
an aerodynamic diameter of 10 μm or less (PM10) and were included in the analysis. Also shown are the annual mean PM10 concentrations. 
See the interactive map, available at NEJM.org.
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ted concentration–response curves using the same 
approach that was used in previous studies.16,19 
In brief, we replaced the linear term of PM in the 
main model with a B-spline function with two 
knots at the 25th and 75th percentiles of the 
mean PM concentrations across all cities.
We performed several sensitivity analyses. First, 
in fitting the concentration–response curves, we 
placed knots at different PM values. Second, we 
tested the potential confounding effect of hu-
midity in cities that had available data on this 
variable by comparing the results of models that 
adjusted for humidity with the results of models 
that did not in a paired z-test. Third, we re-
stricted the analyses to data available after the 
year 2000.
We conducted all statistical analyses with 
R software, version 3.3.1 (R Foundation for Statis-
tical Computing), using the mgcv package for fit-
ting main models and the rmeta package for 
performing random-effect models. A P value of 
less than 0.05 was considered to indicate statis-
tical significance. More details are presented in 
the Methods section in the Supplementary Ap-
pendix.
R esult s
Descriptive Analyses
The final analysis included 59.6 million deaths 
from any cause or nonexternal causes, 20.1 mil-
lion deaths from cardiovascular diseases, and 
5.6 million deaths from respiratory diseases (Ta-
ble S1 [nontrimmed data] and Table S3 [trimmed 
data] in the Supplementary Appendix). On aver-
age, the annual mean concentration of PM10 in 
598 cities was 56.0 μg per cubic meter (median, 
44.3 μg per cubic meter [range, 11.0 to 295.0; 
interquartile range, 37.9 to 70.1]), and the an-
nual mean concentration of PM2.5 in 499 cities 
was 35.6 μg per cubic meter (median, 31.9 μg 
per cubic meter [range, 4.1 to 116.9; interquartile 
range, 21.5 to 43.5]). PM10 was strongly correlated 
with PM2.5, with a mean Pearson correlation co-
efficient of 0.78. The mean Pearson correlation 
coefficients between PM10 and gaseous pollutants 
Figure 2. Distribution of Cities with Data on PM2.5.
Shown is the geographic distribution of the 499 cities in the 16 countries and regions that had data on particulate matter with an aero-
dynamic diameter of 2.5 μm or less (PM2.5) and were included in the analysis. Also shown are the annual mean PM2.5 concentrations. 
See the interactive map, available at NEJM.org.
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were 0.46 with nitrogen dioxide, 0.20 with ozone, 
0.38 with sulfur dioxide, and 0.40 with carbon 
monoxide. The corresponding coefficients be-
tween PM2.5 and gaseous pollutants were 0.48, 
0.22, 0.40, and 0.45. Other descriptive statistics 
and the correlations between daily mean PM 
concentrations and weather variables are sum-
marized in the Results section in the Supple-
mentary Appendix.
Regression Analyses
The choice of a 2-day moving average for PM 
concentration, which represents the average over 
the same and previous day (lag 0 to 1 day), and 
a 4-day moving average for temperature, which 
represents the average of the same and previous 
3 days (lag 0 to 3 days), generated the smallest 
mean generalized cross-validation scores (Tables 
S4 and S5 in the Supplementary Appendix). These 
moving averages were then applied in subsequent 
analyses. For both PM10 and PM2.5, the associa-
tions were significant on lag 0 day and then 
attenuated substantially on lag 1 to 2 days; the 
estimates of the associations were strongest on 
lag 0 to 1 day (Table S4 in the Supplementary 
Appendix).
Overall, we observed positive and significant 
associations between PM10 and PM2.5 concentra-
tions and all-cause mortality (Table 1). In 598 
cities that had data on PM10, an increase of 10 μg 
per cubic meter in the PM10 concentration was 
associated with an increase of 0.44% (95% con-
fidence interval [CI], 0.39 to 0.50) in a pooled 
estimate of daily all-cause mortality. In 499 cities 
that had data on PM2.5, the same increase in the 
PM2.5 concentration was associated with an in-
crease of 0.68% (95% CI, 0.59 to 0.77) in a pooled 
estimate of daily all-cause mortality. The country-
specific estimates of the percentage change in 
daily all-cause mortality showed considerable 
variations, ranging from 0.03% (for Colombia) 
to 1.32% (for Australia) in association with a 
10-μg-per-cubic-meter increase in PM10 concentra-
tion and ranging from 0.03% (for Portugal) to 
2.54% (for Greece) in association with the same 
increase in PM2.5 concentration. Estimates of the 
effect in France, Estonia, and Switzerland were 
close to the global median estimate of 0.46% in 
association with PM10 concentration; estimates 
of the effect in Switzerland and South Africa 
were close to the global median estimate of 0.80% 
in association with PM2.5 concentration.
In cause-specific analyses, an increase of 10 μg 
per cubic meter in PM10 concentration (in 528 
cities) was associated with an increase of 0.36% 
(95% CI, 0.30 to 0.43) in daily cardiovascular 
mortality and an increase of 0.47% (95% CI, 0.35 
to 0.58) in daily respiratory mortality. The corre-
sponding increases in daily cardiovascular and 
respiratory mortality for the same increase in PM2.5 
concentration (in 488 cities) were 0.55% (95% CI, 
0.45 to 0.66) and 0.74% (95% CI, 0.53 to 0.95%) 
(Figs. S1 and S2 in the Supplementary Appen-
dix). In 445 cities that had data on both PM2.5 
and PM10, the percentage increases in all-cause 
mortality per 10-μg-per-cubic-meter increase in 
PM2.5 concentration were larger than those with 
the same increase in PM10 concentration, both in 
the pooled results and in most country-specific 
estimates (Fig. S3 in the Supplementary Appendix).
Regional analyses indicated differences be-
tween areas (Table S6 in the Supplementary Ap-
pendix), with higher estimates of the effect in 
the region of the Americas and smaller estimates 
in the Western Pacific region. We observed 
stronger associations between PM10 and PM2.5 
concentrations and all-cause mortality in loca-
tions with lower annual mean concentrations 
of PM and higher annual mean temperatures 
(P<0.001 for all comparisons); there was no sig-
nificant modification of the effect according to 
annual mean concentrations of PM and copollut-
ants, latitude of location, WHO region and re-
gion classified according to the GDP per capita, 
rates of missing data on daily mortality and PM10 
and PM2.5 concentrations, and GDP per capita 
(P>0.05 for all comparisons).
In two-pollutant models (Table 2), the magni-
tude (i.e., the size of the estimated effect) of the 
associations of PM10 and PM2.5 concentrations on 
lag 0 to 1 day with all-cause mortality decreased, 
but all associations between PM and mortality 
remained significant after adjustment for gaseous 
pollutants. Notably, the estimates of the percent-
age change in mortality per 10-μg-per-cubic-
meter increase in PM10 concentration decreased 
significantly after adjustment for nitrogen dioxide 
(difference of 35%; P<0.001) and sulfur dioxide 
(difference of 18%; P = 0.007). Similarly, the per-
centage change in mortality with the same in-
crease in PM2.5 concentration decreased by 36% 
after adjustment for nitrogen dioxide (P<0.001) 
and by 22% after adjustment for sulfur dioxide 
(P = 0.007).
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The concentration–response associations of 
daily mean PM10 and PM2.5 concentrations with 
all-cause mortality were positive, and the curves 
showed a consistent increase with no discernible 
thresholds (Fig. 3). The slopes for both curves 
were steeper at concentrations lower than 40 μg 
per cubic meter for PM10 and lower than 20 μg per 
cubic meter for PM2.5. The slopes seemed to flat-
ten at high ranges. In addition, positive associa-
tions were still detectable at levels below most 
global and regional air-quality guidelines or stan-
dards. Country-specific concentration–response 
curves are provided in Figures S4 and S5 in the 
Supplementary Appendix.
Sensitivity analyses confirmed these results. 
The use of alternative knots did not substantially 
change the shape of the concentration–response 
curves, and adjustment for humidity resulted in 
Country or Region PM10 PM2.5
Cities with 
Available 
Data Pooled Estimate
Cities with 
Available 
Data Pooled Estimate
no. % (95% CI) no. % (95% CI)
Australia 3 1.32 (0.22 to 2.44) 3  1.42 (–0.12 to 2.99)
Brazil 1 1.22 (0.97 to 1.47) 0 NA
Canada 13 0.76 (0.25 to 1.27) 25 1.70 (1.17 to 2.23)
Chile 4 0.33 (0.14 to 0.53) 4  0.27 (–0.68 to 1.23)
China 272 0.28 (0.22 to 0.34) 272 0.41 (0.32 to 0.50)
Colombia 1  0.03 (–0.34 to 0.39) 0 NA
Czech Republic 1  0.40 (–0.02 to 0.82) 0 NA
Estonia 4  0.46 (–0.69 to 1.63) 3  0.23 (–4.24 to 4.90)
Finland 1  0.07 (–0.51 to 0.65) 1  0.14 (–0.55 to 0.83)
France 18  0.46 (–0.15 to 1.07) 0 NA
Greece 1 0.53 (0.17 to 0.90) 1 2.54 (1.28 to 3.83)
Italy 18 0.65 (0.26 to 1.04) 0 NA
Japan 47 1.05 (0.78 to 1.31) 47 1.42 (1.05 to 1.81)
Mexico 8 0.67 (0.48 to 0.86) 3 1.29 (0.21 to 2.39)
Portugal 2  0.11 (–0.27 to 0.49) 1  0.03 (–1.14 to 1.21)
South Africa 6 0.41 (0.14 to 0.68) 5 0.80 (0.16 to 1.44)
South Korea 7 0.42 (0.27 to 0.58) 0 NA
Spain 45 0.87 (0.60 to 1.15) 19 1.96 (1.18 to 2.75)
Sweden 1  0.20 (–1.03 to 1.44) 1  0.08 (–1.44 to 1.62)
Switzerland 8  0.47 (–0.36 to 1.31) 4  0.79 (–0.96 to 2.58)
Taiwan 3  0.25 (–0.03 to 0.53) 3  0.62 (–0.39 to 1.64)
Thailand 19 0.61 (0.24 to 0.99) 0 NA
United Kingdom 15  0.06 (–0.36 to 0.48) 0 NA
United States 100 0.79 (0.60 to 0.98) 107 1.58 (1.28 to 1.88)
Total 598 0.44 (0.39 to 0.50) 499 0.68 (0.59 to 0.77)
*  Pooled estimates represent the percentage changes in daily all-cause mortality per 10-μg-per-cubic-meter increase in 
concentrations of particulate matter (PM) with an aerodynamic diameter of 10 μm or less (PM10) and PM with an aero-
dynamic diameter of 2.5 μm or less (PM2.5), as determined with the use of trimmed exposure data in which the highest 
5% and lowest 5% of PM10 and PM2.5 measurements were excluded. NA denotes not available.
Table 1. Percentage Change in All-Cause Mortality per 10-μg-per-Cubic-Meter Increase in 2-Day Moving Average 
Concentrations of Inhalable Particulate Matter (PM10) and Fine Particulate Matter (PM2.5).*
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no significant changes (Figs. S6 and S7 and Ta-
ble S7 in the Supplementary Appendix). Finally, 
the analysis in which the subset of data since the 
year 2000 was used provided similar estimates. 
Estimates based on nontrimmed PM data are pro-
vided in Table S8 in the Supplementary Appendix.
Discussion
Our study analyzed multisite data on air pollu-
tion and mortality in 652 cities across different 
countries and regions, although most countries 
and cities were in the northern hemisphere. Be-
cause the data from each city were analyzed ac-
cording to the same protocol, the estimate of 
the percentage change in mortality per 10-μg-
per-cubic-meter increase in PM concentration 
was based on a large data set. This study also 
provides the statistical power to examine the 
global concentration–response functions of par-
ticulate air pollution at both low and high base-
line levels.
In the analysis of PM10, we observed an in-
crease of 0.44% in all-cause mortality per 10-μg-
per-cubic-meter increase in PM10 concentration. 
The magnitude of the association is generally 
similar to previous findings in other multicity or 
multicountry studies.7-9,20 For example, the Air 
Pollution and Health: A European and North 
American Approach (APHENA) study reported 
increases of 0.86%, 0.33%, and 0.29% in daily 
all-cause mortality in Canada, Europe, and the 
United States, respectively.9 The percentage in-
crease in mortality for the same increase in PM10 
concentration was 0.77% in the Multicity Study 
of Air Pollution and Mortality in Latin America 
(ESCALA),8 0.55% in the Public Health and Air 
Pollution in Asia (PAPA) study,7 and 0.19% in the 
reanalysis of the U.S. National Morbidity Mortal-
ity Air Pollution Study (NMMAPS).21
In the analysis of PM2.5, we observed an in-
crease of 0.68% in all-cause mortality per 10-μg-
per-cubic-meter increase in PM2.5 concentration. 
Our estimates were somewhat smaller than those 
obtained from previous multicity studies and a 
meta-analysis that used data mainly from devel-
Figure 3. Pooled Concentration–Response Curves.
Shown are the pooled concentration–response curves for the associations of 2-day moving average concentrations of PM10 (Panel A) 
and PM2.5 (Panel B) with daily all-cause mortality. The y axis represents the percentage difference from the pooled mean effect (as de-
rived from the entire range of PM concentrations at each location) on mortality. Zero on the y axis represents the pooled mean effect, 
and the portion of the curve below zero denotes a smaller estimate than the mean effect. The dashed lines represent the air-quality 
guidelines or standards for 24-hour average concentrations of PM10 or PM2.5 according to the World Health Organization Air Quality 
Guidelines (WHO AQG), WHO Interim Target 1 (IT-1), WHO Interim Target 2 (IT-2), WHO Interim Target 3 (IT-3), European Union Air 
Quality Directive (EU AQD), U.S. National Ambient Air Quality Standard (NAAQS), and China Air Quality Standard (AQS).
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oped countries.22,23 This difference may be inter-
preted as reflecting the nonlinearity of our 
concentration–response curve, which indicated a 
steeper slope at lower concentrations. In addition, 
we found that the associations of mortality with 
PM concentrations were slightly stronger with 
PM2.5 than with PM10 in most countries and re-
gions, which added to the evidence that PM2.5 
accounted for a larger proportion of the effects 
of PM10 and PM2.5 combined.
6 The stronger ef-
fects of PM2.5 may also be supported by the 
abundant evidence that this particulate fraction 
contains more small particles that can absorb 
toxic components from the air and penetrate 
deep into the lungs.24
The question of whether the observed asso-
ciations for PM were independent from other 
pollutants is important for air-quality regulation 
and health-risk assessment. In our data, although 
the magnitude of the associations for PM10 and 
PM2.5 decreased in two-pollutant models, the as-
sociations for both remained significant, a find-
ing that provides evidence of the independent 
health effects of PM. It is notable that the esti-
mates of the percentage change in mortality per 
10-μg-per-cubic-meter increase in PM10 and PM2.5 
concentrations decreased more after adjustment 
for nitrogen dioxide and sulfur dioxide than af-
ter adjustment for ozone and carbon monoxide, 
a finding that may be interpreted as reflecting 
closer correlations of PM with nitrogen dioxide 
and sulfur dioxide caused by similar sources and 
seasonal patterns.
In accordance with the findings from the 
majority of previous studies, the concentration–
response curves between PM concentration and 
daily mortality derived from this global study 
showed a consistent increase without evidence of 
a threshold.16,19,22 In both curves, the percentage 
increase in mortality per unit change in PM con-
centration seemed to be smaller (i.e., the con-
centration–response curves seemed to flatten) at 
high ranges of daily mean PM concentration. This 
potential saturation effect may be explained by 
smaller effects of changes in daily mean PM 
concentration in cities with higher baseline levels 
of PM, as suggested in our meta-regression analy-
ses. Furthermore, the higher proportion of young 
people in developing countries may decrease 
population susceptibility to PM, and less out-
door activity during days with high pollution 
levels may decrease exposure. Nevertheless, the 
concentrations of PM below the current air-
quality guidelines and standards may still be 
hazardous to public health. However, associa-
tions estimated for extreme PM concentrations 
are characterized by wider confidence intervals, 
with greater uncertainty about the actual mortal-
ity risk at such values. We should also be cautious 
about the uncertainty in the concentration– 
response curves, because they were pooled from 
cities or countries with diverse PM ranges and 
varying population susceptibility and data qual-
ity and representability.
We found significant evidence of spatial hetero-
geneity in the associations between PM concen-
tration and daily mortality across countries and 
regions. A number of factors could contribute to 
this variability, including different PM compo-
nents, long-term air pollution levels, population 
susceptibility, and different lengths of study peri-
ods. We also found that higher annual mean 
concentrations of PM10 and PM2.5 were accompa-
nied by weaker associations with daily mortality, 
a finding that has been reported in previous 
studies.16,25 The possible adaptive response to PM 
in populations living in areas with higher long-
term exposure to PM may lead to smaller esti-
mate-per-unit changes in exposure. In addition, 
we identified stronger associations of PM with 
mortality in regions with higher GDP per capita, 
which may also be in relation to lower long-term 
air pollution levels (Pearson coefficient, –0.68 
for PM10 and –0.74 for PM2.5) and decreased 
population susceptibility due to higher socioeco-
nomic status.26 The estimates of the association 
between PM and mortality in some countries 
(e.g., France, Finland, Sweden, and the United 
Kingdom) were smaller and not significant. 
These countries had fewer cities included and 
shorter periods evaluated, which may increase 
the statistical uncertainty in the estimation of 
the effect. Furthermore, these countries are gen-
erally located in areas with a low annual mean 
temperature, which may decrease the association 
between PM and mortality, as shown in meta-
regression analyses. More interpretations on this 
issue are provided in the Discussion section in 
the Supplementary Appendix.
This study has several limitations. First, al-
though the analysis included 24 major countries 
and regions on six continents, our findings can-
not be interpreted as fully globally representative 
because the 652 cities were mainly located in 
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East Asia, Europe, and North America, with a 
smaller number of cities in Latin America and 
Africa. Second, we relied on fixed-site environ-
mental measurements, which could introduce ex-
posure misclassification. Third, diagnostic or cod-
ing errors in health data are also inevitable in 
such a global study that spans multiple decades; 
the effects of these errors on our results are dif-
ficult to evaluate, which presumably makes the 
estimates of the effects on cause-specific mortal-
ity less reliable than those of effects on all-cause 
mortality. Fourth, there are some missing data, 
but their influence on our estimates was not 
substantial (see the Discussion section and Table 
S9 in the Supplementary Appendix).
Our multicountry time-series analysis provides 
evidence on positive associations between short-
term exposure to PM10 and PM2.5 and daily all-
cause, cardiovascular, and respiratory mortality. 
This study indicated independent associations of 
PM10 and PM2.5 concentrations with daily mortal-
ity after adjustment for gaseous pollutants. Fur-
ther, concentration–response curves for the ef-
fects of PM on mortality showed a consistent 
increase, with flattening of the slopes at higher 
concentrations, and the associations were still 
detectable at concentrations below the current 
air-quality guidelines and regulatory limits.
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